首页> 美国卫生研究院文献>Kidney Diseases >Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease

【2h】

Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease

机译：改善慢性肾病患者抑郁症的检测和评价：慢性肾病抑制筛查（PHQ-2）和诊断（BDI-FS-FR）试验的抑制性和可靠性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Depression is underdiagnosed and thus undertreated. This study aimed to validate the French version of the PHQ-2 (Patient Health Questionnaire-2) and BDF-FS-Fr (Beck Depression Inventory-Fast Screen-France) on patients with chronic kidney disease (CKD) living in France.

机译：抑郁症被诊断并因此令人未知。本研究旨在验证法国慢性肾脏疾病（CKD）患者的PHQ-2（患者健康问卷-2）和BDF-FS-FR（Beck Depresse-Fast-Fast-Fast Screen-France）的法国版。

著录项

期刊名称 Kidney Diseases
作者
Muaweah Alsaleh; Ludivine Videloup; Thierry Lobbedez; Joelle Lebreuilly; Remy Morello; Angélique Thuillier Lecouf;
展开▼
作者单位

展开▼
年(卷),期 2019(5),4
年度 2019
页码 228–238
总页数 11
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词

机译：慢性肾病;抑郁症;筛选;诊断;PHQ-2;BDI-FS-FR;可靠性;有效性;规模;心理学特征;法语;

相似文献

外文文献
中文文献
专利

1. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study [J] . Melanie?P. Chin, George?L. Bakris, Geoffrey?A. Block, American Journal of Nephrology . 2018,第1期

机译：Bardoxolone甲基提高了慢性肾病阶段4和2型糖尿病患者的肾功能：在慢性肾病患者和2型糖尿病研究中，HARDOXOLENE甲基评估后HOC分析
2. SAT-310 BECK DEPRESSION INVENTORY AND SF-36 AS SCREENING TOOLS FOR DEPRESSION AND ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE AMONG CHRONIC KIDNEY DISEASE PATIENTS ON HEMODIALYSIS [J] . R. SAROSONG, M.A. Chong-Lu Kidney International Reports . 2020,第3期

机译：SAT-310 Beck抑郁症和SF-36作为血液透析患者慢性肾病患者抑郁和评估健康相关生活质量的筛选工具
3. The prevalence of depression and the association between depression and kidney function and health-related quality of life in elderly patients with chronic kidney disease: a multicenter cross-sectional study [J] . Wen-Ling Wang, Shuang Liang, Fang-Lei Zhu, Clinical Interventions in Aging . 2019,第1期

机译：老年慢性肾脏病患者的抑郁症患病率以及抑郁症和肾脏功能与健康相关的生活质量的关系：多中心横断面研究
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Evaluation of a Protocol Change to Improve Screening of Mineral Bone Disorders in Patients With Stage 3 Chronic Kidney Disease [D] . Kelly, Jarena 2011

机译：评估协议变更以改善3期慢性肾脏病患者矿物质骨疾病筛查的评估
6. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study [O] . Melanie P. Chin, George L. Bakris, Geoffrey A. Block, -1

机译：Bardoxolone甲基改善慢性肾脏病4期和2型糖尿病患者的肾功能：Bardoxolone甲基评估慢性肾脏病和2型糖尿病患者的Hoc分析
7. Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease [O] . Muaweah Alsaleh, Ludivine Videloup, Thierry Lobbedez, 2019

机译：改善慢性肾病患者抑郁症的检测和评价：慢性肾病抑制筛查（PHQ-2）和诊断（BDI-FS-FR）试验的抑制性和可靠性

Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease

摘要

著录项

相似文献

相关主题

期刊订阅